Recall record at a glance
| Official record | F-1067-2022 |
|---|---|
| Category | Food Recalls |
| Classification | Class III |
| FDA record status | Terminated |
| Recalling firm | Driscoll's Inc. |
| Report date | May 25, 2022 |
| Recall initiation date | Apr 15, 2022 |
| Quantity | 1,293 crates |
| Location | Watsonville, CA, United States |
Official product description
Driscoll's Blackberries (Fresh) 12x6 oz, 12x12 oz, 12x10 oz, 2x8x18 oz Clamshell Distributed by Strawberry Associated, Inc. Watsonville, CA Product of Mexico
Why the product was recalled
California Department of Pesticide Regulation detected the presence of Formetante HCI. This pesticide has a non-tolerance for blackberries.
Distribution information
Product shipped to 13 DC's located in CA, TX, OR, IL, MD, FL, NC, WI
How to read the classification
FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.